LivaNova (LIVN) Profit After Tax (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.87% |
| Dec 31, 2025 | 15.39% |
| Sep 30, 2025 | -1.39% |
| Jun 30, 2025 | 108.30% |
| Mar 31, 2025 | -685.64% |
| Dec 31, 2024 | 69.61% |
| Sep 30, 2024 | 101.76% |
| Jun 30, 2024 | 138.94% |
| Mar 31, 2024 | -356.70% |
| Dec 31, 2023 | 323.27% |
| Sep 30, 2023 | -733.59% |
| Jun 30, 2023 | -84.33% |
| Mar 31, 2023 | 343.71% |
| Dec 31, 2022 | 101.55% |
| Sep 30, 2022 | -752.79% |
| Jun 30, 2022 | 449.42% |
| Mar 31, 2022 | 158.38% |
| Dec 31, 2021 | 88.20% |
| Sep 30, 2021 | 23.09% |
| Jun 30, 2021 | -83.63% |
| Mar 31, 2021 | 89.04% |
| Dec 31, 2020 | -1,793.83% |
| Sep 30, 2020 | 83.43% |
| Jun 30, 2020 | -338.73% |
| Mar 31, 2020 | 126.12% |
| Dec 31, 2019 | -546.53% |
| Sep 30, 2019 | 209.94% |
| Jun 30, 2019 | -96.75% |
| Mar 31, 2019 | 92.91% |
| Dec 31, 2018 | -3,240.33% |
| Sep 30, 2018 | -141.64% |
| Jun 30, 2018 | -15.46% |
| Mar 31, 2018 | 156.66% |
| Dec 31, 2017 | -213.03% |
| Sep 30, 2017 | -39.07% |
| Jun 30, 2017 | 305.28% |
| Mar 31, 2017 | 278.73% |
| Dec 31, 2016 | -301.91% |
| Sep 30, 2016 | -112.32% |
| Jun 30, 2016 | 131.54% |
| Oct 18, 2015 | -302.04% |
| Jul 24, 2015 | 18.12% |